文献速递角膜与眼表疾病

培养口腔黏膜上皮移植联合术后角膜缘硬性接触镜佩戴治疗终末期眼表疾病的策略性组合:一项回顾性队列研究

Strategic combination of cultivated oral mucosal epithelial transplantation and postoperative limbal-rigid contact lens-wear for end-stage ocular surface disease: a retrospective cohort study.
PubMed 文献 · Br J Ophthalmol · 2024-07-23

该回顾性队列纳入2002至2019年接受培养口腔黏膜上皮移植(COMET)并术后佩戴角膜缘硬性接触镜至少1年的18例严重眼表疾病患者共23眼,随访显示最佳矫正视力从基线logMAR 1.9±0.5改善至最终logMAR 1.3±0.7(p<0.05),睑球粘连及上下穹窿缩短的眼表分级评分在各随访时间点均较基线显著改善,未观察到严重术中或术后不良事件。

要点

  • COMET联合术后角膜缘硬性接触镜佩戴可改善严重眼表疾病患者的视力。
  • 睑球粘连和上下穹窿缩短的眼表分级评分在各随访时间点较基线显著改善。
  • 未观察到严重术中或术后不良事件。

核心结论

  • 在严重眼表疾病患者中,COMET联合术后角膜缘硬性接触镜佩戴治疗对视力改善和眼表稳定有效。

研究设计与样本

  • 回顾性队列研究,纳入2002至2019年接受COMET手术并术后接受角膜缘硬性接触镜佩戴治疗随访至少1年的18例严重眼表疾病患者共23眼。

主要发现

  • 研究纳入16例Stevens-Johnson综合征患者和2例黏膜类天疱疮患者,平均年龄59±15岁。
  • COMET手术指征为:为改善视力行角膜重建10眼(43.5%),为持续性上皮缺损行角膜重建4眼(17.4%),为睑球粘连松解行结膜(穹窿)重建9眼(39.1%)。
  • 术后佩戴接触镜的平均时长为6.4±3.9年(范围1.4至13.3年)。
  • 基线平均最佳矫正视力为logMAR 1.9±0.5,最终随访时为logMAR 1.3±0.7(p<0.05)。
  • 与基线相比,睑球粘连和上下穹窿缩短的眼表分级评分在治疗开始后各随访时间点均显示显著改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide the long-term outcome of patients with end-stage severe ocular surface disease (OSD) consecutively treated with cultivated oral mucosal epithelial transplantation (COMET) followed by limbal-rigid contact lens (CL)-wear therapy. DESIGN: Retrospective cohort. METHODS: In 23 eyes of 18 patients with severe OSD who underwent COMET surgery between 2002 and 2019 and who were followed with limbal-rigid CL-wear therapy for at least 1 year postoperative, patient demographics, best-corrected visual acuity (BCVA, logMAR), Ocular Surface Grading Scores (OSGS), surgical indication and adverse events were reviewed. Primary and secondary outcomes were BCVA and OSGS changes at baseline and final examination, respectively. RESULTS: This study involved 16 patients with Stevens-Johnson syndrome and 2 patients with mucous membrane pemphigoid (mean age: 59±15 years). The indications for COMET were as follows: corneal reconstruction for vision improvement (10 eyes (43.5%)), corneal reconstruction for persistent epithelial defect (4 eyes (17.4%)) and conjunctival (fornix) reconstruction for symblepharon release (9 eyes (39.1%)). The mean duration of CL-wear postsurgery was 6.4±3.9 years (range: 1.4 to 13.3 years). The mean BCVA at baseline and at final follow-up was logMAR 1.9±0.5 and 1.3±0.7, respectively (p<0.05). Compared with those at baseline, the OSGSs for symblepharon and upper and lower fornix shortening showed significant improvement at each follow-up time point post treatment initiation. No serious intraoperative or postoperative adverse events were observed. CONCLUSION: In patients afflicted with severe OSD, COMET combined with limbal-rigid CL-wear therapy postsurgery was found effective for vision improvement and ocular surface stabilisation.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Aziza Y, Imai K, Itoi M, et al. Strategic combination of cultivated oral mucosal epithelial transplantation and postoperative limbal-rigid contact lens-wear for end-stage ocular surface disease: a retrospective cohort study. Br J Ophthalmol. 2024. PMID: 37918892. doi:10.1136/bjo-2023-323617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。